Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Knowing when to start saving for retirement is essential for financial security. Explore the best timing for your savings plan.
24,441 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Rivian unveils the R2 with a sub-$45k price target and near-term shipments, while Lucid battles cash burn and no 2026...
JAUST launches a cloud-native automated underwriting platform designed for jumbo mortgage originations, aiming to cut...
Considering international real estate for income? This article breaks down HAUZ and VNQ, showing how they differ, wha...
Bitcoin pulled back toward $68,000 as new geopolitical threats stoked risk-off sentiment. Traders weigh whether the d...
Bittensor's $52 million annual subsidy governs the network's top subnets, creating an 'income desert' that could unra...
Gas prices break above $4.50 per gallon nationwide as Middle East tensions surge, squeezing wallets ahead of peak dri...
April’s jobs data shows a broad recovery in payrolls, but the information and finance sectors continue to lag, highli...
A bearish pattern on the Kospi hints that U.S. chip shares may face further selling as regional markets turn cautious...
Warren Buffett's century-spanning Dow forecast remains a talking point as the index sits in the mid-30,000s in 2026. ...
Bolt is reshaping its growth plan after a sweeping HR shakeup and large-scale layoffs. The fintech aims to regain spe...
As global tensions rise, borrowing costs and lenders' risk appetites shift. This guide explains why the housing marke...